TriSalus Life Sciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
/ 
Frequently asked questions
To buy TriSalus Life Sciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for TriSalus Life Sciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for TriSalus Life Sciences Inc. is TLSI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
TriSalus Life Sciences Inc. has its primary listing on NASDAQ. You can trade TriSalus Life Sciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, TriSalus Life Sciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include TriSalus Life Sciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like TriSalus Life Sciences Inc..